Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Eduardo Díaz‐Rubio

Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated With Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy

Oncologist
Cancer ResearchMedicineOncology
2019English

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2013English

Related publications

Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy With Cetuximab, Temozolomide, and Radiation

Frontiers in Oncology
Cancer ResearchOncology
2013English

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma

PLoS ONE
Multidisciplinary
2016English

Comprehensive Pharmacogenetic Profiling of the Epidermal Growth Factor Receptor Pathway for Biomarkers of Response To, and Toxicity From, Cetuximab

Journal of Medical Genetics
Genetics
2017English

P3.01-033 Detection of Epidermal Growth Factor Receptor Mutations With Plasma Sample Compared With Tumor Tissue Biopsy in Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Epidermal Growth Factor Receptor Mutation and Chemosensitivity: In Response

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Pseudoprogression and Rapid Response to Pembrolizumab in a Patient With Advanced Lung Adenocarcinoma With Loss of Epidermal Growth Factor Receptor Gene Mutation After Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Role of Epidermal Growth Factor Receptor in Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy